EE404 Economic Value of Dupilumab in Preventing and Treating Comorbid Asthma in Pediatric Patients With Atopic Dermatitis: A Cost-Offset Model From the Italian Payer Perspective
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.787
https://www.valueinhealthjournal.com/article/S1098-3015(25)03344-3/fulltext
Title :
EE404 Economic Value of Dupilumab in Preventing and Treating Comorbid Asthma in Pediatric Patients With Atopic Dermatitis: A Cost-Offset Model From the Italian Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03344-3&doi=10.1016/j.jval.2025.09.787
First page :
Section Title :
Open access? :
No
Section Order :
10356